ABILITY Neurotech has secured approval from the MREC NedMec in the Netherlands to initiate a chronic clinical trial of its fully implantable wireless BCI in patients with ALS. The post ABILITY Neurotech receives MREC approval for ALS BCI clinical trial appeared first on Hospital Management.
ABILITY Neurotech has secured approval from the MREC NedMec in the Netherlands to initiate a chronic clinical trial of its fully implantable wireless BCI in patients with ALS.The post ABILITY Neurotech receives MREC approval for ALS BCI clinical trial appeared first on Hospital Management.
